Abacus Health Products, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2019; Provides Revenue Guidance for the Fourth Quarter of 2019
For the nine months, revenue was $11,118,478 compared to $5,579,000 a year ago. Net and comprehensive loss was $12,007,306 compared to income of $1,044,713 a year ago. Loss per share - basic was $0.64.
Based on existing and anticipated purchase orders the company expects fourth quarter 2019 revenue to result in quarterly sequential growth of 20%-25%, and in particular driven by CBDMEDIC in the F/D/M channel.